Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series-Reference-Cited by-同舟云学术

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series

Published:2012-10 Issue:5 Volume:79 Page:457-463
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Toussirot Éric,Houvenagel Éric,Goëb Vincent,Fouache Damien,Martin Antoine,Le Dantec Philippe,Dernis Emmanuelle,Wendling Daniel,Ansemant Thiphaine,Berthelot Jean-Marie,Bader-Meunier Brigitte,Kantelip Bernadette

Publisher

Elsevier BV

Subject

Rheumatology

Reference25 articles.

1. Etanercept for active Crohn's disease: a randomized double blind, placebo-controlled trial;Sandborn;Gastroenterology,2001

2. Paradoxical adverse events of anti-tumour necrosis factor therapy for spondylarthropathies: a retrospective study;Fouache;Rheumatology,2009

3. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases;Immediato-Daiën;Rheumatology,2009

4. Colon inflammatory;Montgommery,2005

5. Development of Crohn's disease in a patient taking etanercept;Oh;J Rheumatol,2005

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?;Reumatología Clínica;2023-12

2. Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review;Life;2023-08-20

3. Tumor necrosis factor-α inhibitor-related autoimmune disorders;Autoimmunity Reviews;2023-07

4. Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies;Nature Reviews Rheumatology;2023-06-29

5. Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics;Journal of Pediatric Gastroenterology & Nutrition;2022-11-18